Risk Minimisation Materials

Obizur reconstitution video

Instruction video on reconstitution of Obizur

For Healthcare Professionals

OBIZUR▼[antihaemophilic Factor VIII (recombinant), porcine sequence] HCP Brochure

Information On Dose Calculation for OBIZUR▼[antihaemophilic Factor VIII (recombinant), porcine sequence]

For Healthcare Professionals

Olumiant 2 mg and 4 mg Film-Coated Tablets guidance for Healthcare Professionals for Atopic Dermatitis

Important Risk Minimization information for healthcare professionals prescribing Olumiant for the treatment of Atopic Dermatitis.

For Healthcare Professionals

Olumiant 2 mg and 4 mg Film-Coated Tablets guidance for Healthcare Professionals for Rheumatoid Arthritis

Important Risk Minimization information for healthcare professionals prescribing Olumiant for the treatment of Rheumatoid Arthritis.

For Healthcare Professionals

Olumiant 2 mg and 4 mg Film-Coated Tablets Patient Alert Card

Olumiant 2 mg and 4 mg Film-Coated Tablets Patient Alert Card containing important safety information for patients.

Onpattro (patisiran) Educational Material for Healthcare Professionals

Educational Material for Healthcare Professionals to ensure safe use of Onpattro in the home setting.

For Healthcare Professionals

Onpattro (patisiran) Educational Material for Patients

Educational Material for patients for safe use of Onpattro in the home.

Opdivo (nivolumab) Patient Alert Card

The provision of this card to patients is required by the terms of the Marketing Authorisation. Please ensure that you carry this card with you at all times and that you have read and understood this information as it contains important safety information that you need to be aware of before, during and after treatment with nivolumab or nivolumab in combination with ipilimumab. This card was updated in July 2020. Changes to the card include design/editorial updates, removal of the black inverted triangle symbol (and associated wording) and an updated reporting of side effects statement.

ADR & AE Form

Adverse Event (AE)/Adverse Drug Reaction (ADR) Form

For Healthcare Professionals

Opsumit cover letter for HCP

Notification of updated risk management materials for Opsumit (macitentan).

For Healthcare Professionals

Opsumit HCP Brochure UK

Introduction to Opsumit, what its used for, indication and how it should be used

For Healthcare Professionals

Opsumit Patient Alert Card

It is important that you report immediately to your prescribing doctor any pregnancy or side effects that may occur during treatment with Opsumit.

For Healthcare Professionals

Opsumit Pregnancy Form

Pregnancy diagnostic form

For Healthcare Professionals

prescribers Checklist

Checklist for the physician before prescribing Opsumit to the patient.

For Healthcare Professionals

Oruvail Gel- Checklist for Patients

For hard copies please contact our medical information department at 0800 035 2525 or email [email protected]

Oruvail Gel -Checklist for prescriber

For hard copies please contact our medical information department at 0800 035 2525 or email [email protected]

For Healthcare Professionals

Ozurdex - Patient Guide

A patient guide to OZURDEX therapy